Cargando…
Advances in the understanding and management of T-cell prolymphocytic leukemia
T-prolymphocytic leukemia (T-PLL) is a rare T-cell neoplasm with an aggressive clinical course. Leukemic T-cells exhibit a post-thymic T-cell phenotype (Tdt(−), CD1a(−), CD5(+), CD2(+) and CD7(+)) and are generally CD4(+)/CD8(−), but CD4(+)/CD8(+) or CD8(+)/CD4(−) T-PLL have also been reported. The...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732835/ https://www.ncbi.nlm.nih.gov/pubmed/29262669 http://dx.doi.org/10.18632/oncotarget.22272 |